Crispr Therapeutics Plans to Launch Its First Clinical Trial in 2018

Photo by wired.com
 

In late 2012, French microbiologist Emmanuelle Charpentier approached a handful of American scientists about starting a company, a Crispr company.

They included UC Berkeley’s Jennifer Doudna, George Church at Harvard University, and his former postdoc Feng Zhang of the Broad Institute—the brightest stars in the then-tiny field of Crispr research.

Back then barely 100 papers had been

 
 
Note: - If you like the post "Crispr Therapeutics Plans to Launch Its First Clinical Trial in 2018" please share it on your Facebook, Twitter, Google+ or LinkedIn, also post your comment or opinion
 

 

Leave a Reply

Your email address will not be published. Required fields are marked *